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Efficacy of biventricular cardiac resynchronization therapy in patients
with heart failure and permanent atrial fibrillation
Julien Delobelle [Orateur] Hugues Blangy
ILCV Louis Mathieu, Cardiologie, Nancy, France
Objectives: A minority of studies have focused on cardiac resynchroni-
zation therapy in patients with permanent atrial fibrillation. Our goal is to
evaluate this technique in these patients.
Methods: Our study included retrospectively 60 consecutive patients (age
69.8±7.5 yo, 50% of ischemic heart disease, LVEF 0.26±0.06) in permanent
atrial fibrillation patients implanted between January 2005 and June 2010 at
the University Hospital of Nancy with a system of bi-ventricular resynchroni-
zation (32 defibrillators and 28 pacemakers).
Results: After a mean follow up of 20.7±13 months functional improve-
ment was observed in 57.6% of patients and a significant increase in LVEF of
5.7% (p=0.003) was noticed. Fifty percent of patients were ablated of the His
bundle and 80% of non-ablated patients had a preexistant complete atrio-
ventricular block. For similar age and LVEF patients with a system of bi-ven-
tricular resynchronization with a pacemaker die sooner than patients with a
system of bi-ventricular resynchronization with a defibrillator (p=0.02) and
experience less functional improvement (p=0.03). Finally we have found no
difference in terms of underlying heart disease and procedure (primoimplanta-
tion or upgrading).
Conclusions: Biventricular resynchronization therapy improves symptoms and
LVEF in patients with permanent atrial fibrillation if capture is permanent.
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Feasibility, safety and cost effectiveness of same-day discharge after
common atrial flutter radiofrequency catheter ablation
Alexandre Schatz [Orateur] Babe Bakouboula, Francois Bronner, Michel
Chauvin
Nouvel Hôpital Civil, Strasbourg, France
Rationale: Commonly performed during an overnight hospital stay, radio-
frequency Catheter Ablation (RCA) of cavotricuspid isthmus is the curative
treatment of common atrial flutter (FLA). The low complication rate of such
procedures previously reported, points at their feasibility in same-day dis-
charge patients.
Objectives: The present study aims at evaluating the feasibility and the
safety of same day discharge RCA (ambulatory, Amb), and at examining the
cost-effectiveness of RCA during same-day discharge or overnight hospital
stay (OH) in french health care system.
Methods: 100 consecutive patients with FLA referred to the catheter labo-
ratory for RCA were included in this prospective, monocenter study from July
2008 to October 2009 (OH: n=57; Amb: n=43). The economic approach was
based on the analysis of hospital charges.
Results: The clinical characteristics (age, sex ratio, body mass index) were
similar in the two subgroups except for the left ejection fraction. A 90% suc-
cess rate assessed by bidirectional isthmus block (OH: 87.7% and Amb: 93%)
was achieved by the procedure. 64% of the patients showed an atrial flutter
pattern at the beginning of RCA among which 84% were presented a cavotri-
cuspid isthmus-dependant mechanism. After a mean follow-up of 295 days, an
ECG-documented FLA recurrence was evidenced in 8 patients (OH: n=5;
Amb: n=3). No major vascular complication was noticed. We observed
5 minor local haematoma that did not delayed patient's discharge (OH: n=3;
Amb: n=2). On the economic point of view and with respect to the health care
quotation, the cost of the same day discharge appeared less expansive than
that of the overnight hospital stay.
Conclusion: Ambulatory RCA is feasible, safe with a high success rate
and few complications and may reduce the cost of medical care. The same-day
discharge could be viewed as a medical alternative to hospitalization taking
into account the management of the hospital accommodation capacities and
patients' wishes.
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Nightmare regularity of ventricular tachycardia RR intervals in ICD
treated patients
Athanasios G Manolis [Orateur], Kostas Kouvelas, George Nikitas, George
Manolis
Hellenic Red Cross Hospital of Athens, Cardiology, Athens, Greece
Introduction: Ventricular tachycardia cycle length (VTCL) is usually sta-
bilized after a few cycles from its onset.
The aim of the study was to evaluate the possible existence of a nightmare
modulation of VTCL stability in ICD recipients suffered from DCM, low
LVEF and clinical episodes of VT.
Method: We retrospectively evaluated 15 pts with VT episodes occurred
both at day and night time, treated by ICD. In a FU period of 5±3years, we
studied 84 VT episodes (60 at the day and 24 at the might time). As an index
of VTCL stability we considered the coefficient of variance (CV=SD/Mean
RR X 100) of the first 10 consecutive RR intervals stored in the ICD device
during day and night time.
Results: The mean VTCL was 340±29 ms and 352± 45 ms (p=NS)
during day and night time, respectively. The mean CVRR was 2,83±0,52 and
3,36±0,68 (p=0.017) during day and night time, respectively.
Conclusions: The VTCL is less stable during night compared to the day
time, in pts with DCM. A possible explanation is that, the nightmare alteration
of the sympathovagal balance modifies the electrophysiological properties of
the arrhythmogenic substrate. The clinical significance of this study is towards
programming the detection parameters of the ICD (e.g. stability criterion), as
well as programming the schemes of antitachycardia pacing.
